Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

氟美童 - NMPA Drug Approval Details

Approvals/NMPA/Fluorometholone Eye Drops

Approved

化学药品

Fluorometholone Eye Drops

SANTEN PHARMACEUTICAL CO., LTD.🇨🇳 National Medical Products Administration

Approval Date: Nov 4, 2022
Approval ID: 0b7b1815f5929be5
Company: SANTEN PHARMACEUTICAL CO., LTD.
Type: 化学药品

Approval Details

Approval Id: 0b7b1815f5929be5
Approval Number: 国药准字HJ20181090
Generic Name: 氟米龙滴眼液
Generic Name En: Fluorometholone Eye Drops
Trade Name: 氟美童
Drug Type: 化学药品
Dosage Form: 滴眼剂
Strength: 0.1%(5ml:5mg)
Reg Date: 2022-11-04
Expired Date: 2027-11-03
Company Name: SANTEN PHARMACEUTICAL CO., LTD.
Company Detail Path: /organization/santen-pharmaceutical-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Nov 4, 2022

Approval ID

0b7b1815f5929be5

Type

化学药品

Back to NMPA Approvals